izvor podataka: crosbi
✓
What can we learn from studies comparing linezolid with vancomycin in neutropenic patients when vancomycin dosages are not optimized? Reply to Tattevin and Camus (CROSBI ID 128287)
Prilog u časopisu | Pismo (znanstveno) | međunarodna recenzija
Jakšić, Branimir ; Martinelli, Giovanni ; Perez-Oteyza, Jaime ; Hartmen, Charlotte ; Leonard, Linda ; Tack, Kenneth
What can we learn from studies comparing linezolid with vancomycin in neutropenic patients when vancomycin dosages are not optimized? Reply to Tattevin and Camus // Clinical infectious diseases, 42 (2006), 12; 1814-1815-x
Podaci o odgovornosti
Jakšić, Branimir ; Martinelli, Giovanni ; Perez-Oteyza, Jaime ; Hartmen, Charlotte ; Leonard, Linda ; Tack, Kenneth
engleski
What can we learn from studies comparing linezolid with vancomycin in neutropenic patients when vancomycin dosages are not optimized? Reply to Tattevin and Camus
Reply to Tattevin and Camus:What can we learn from studies comparing linezolid with vancomycin in neutropenic patients when vancomycin dosages are not optimized
Linezolid
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
Povezane osobe
Povezane ustanove
